More than 50 consumer and patient groups want the Biden Administration to aggressively protect Americans from medical bills and debt collectors. The effort follows a KHN/NPR investigation.
Increasingly, private equity firms shape staffing decisions at hospital emergency rooms, research shows. One apparent effect: Hiring fewer doctors and more health care practitioners who earn far less.
Drugmakers will be required to pay Medicare back for price increases that outpace inflation. The industry is expected to put up a fight over implementation.
JPMorgan's cheery confab returned to San Francisco, but the health care capitalists had economic anxiety, too.
A hospital's cost calculator said her procedure would be $1,400 for patients without insurance. Instead, the bill was almost $18,000 and, her part was more than $5,000 — the balance of her deductible.
The U.S. health system now produces debt on a mass scale, a new investigation shows. Patients face gut-wrenching sacrifices.
After baby Dorian Bennett arrived two months early and spent more than 50 days in the neonatal ICU, his parents received a bill of more than $550,000 — despite having health insurance.
A student sought counseling help after panicking over a tuition bill. A weeklong stay in a psychiatric hospital followed — along with a $3,413 bill. The hospital soft-pedaled its charity care policy.
A new federal health care rule requires hospitals to publicly post prices for every service they offer and break down those prices by component and procedure.
The president-elect has vowed to strengthen the Affordable Care Act, which gave millions of Americans health insurance. But many insured people still struggle to pay for health care, research finds.
When the hospital tried to bill her for more than what she'd been quoted, Tiffany Qiu refused to pay the extra amount and the bill went to collections. She still didn't back down.
A cook at a senior center, Matthew Fentress is one of millions of Americans whose skimpy health insurance plans leave them vulnerable to huge out-of-pocket costs when they get sick.
The first gene therapy for hemophilia could be approved by the FDA within six months, according to the drugmaker, raising hopes among families. But the drug's price could be $3 million per patient.